Covid-19 roundup: Controversy around colchicine percolates after study failure; AstraZeneca's meeting with EU was 'constructive,' but didn't solve much
A group of researchers at the Montreal Heart Institute has spelled out what they had called positive results suggesting that colchicine, an inexpensive oral anti …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.